2015
DOI: 10.1007/s13277-015-3141-8
|View full text |Cite
|
Sign up to set email alerts
|

The expression of CDK1 is associated with proliferation and can be a prognostic factor in epithelial ovarian cancer

Abstract: Overexpression of cyclin-dependent kinase 1 (CDK1) has been noted to correlation with several human cancers. However, the effects of CDK1 on ovarian cancer development remain unclear. The aim of this study was to examine the effect of CDK1 and related mechanism in the proliferation and resistance to chemotherapeutic drugs of epithelial ovarian cancer (EOC). Immunohistochemical analysis was performed in 119 human ovarian cancer samples, and the data were correlated with clinicopathologic features. Furthermore, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
38
0
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 52 publications
(43 citation statements)
references
References 20 publications
3
38
0
1
Order By: Relevance
“…CDK1, a cell cycle regulator CDK family member, is the key molecule of the ATM-chk2-CDC25-CCNB1/CDK1 pathway that controls the cell cycle [24,25]. Xi et al showed that CDK1 expression is associated with ovarian cancer cell proliferation and can serve as an independent prognostic factor [26]. CCND1 stimulates G1 progression in responding to growth factor stimulation [27]; miR-211 down-regulation results in CCND1 and CDK6 overexpression, which increases the proliferative ability of EOC cells [28].SMARCD1, whose high expression predicts poorer prognosis in gastric cancer, functions as an oncogene by promoting gastric cancer cell proliferation, migration and invasion [29].…”
Section: Discussionmentioning
confidence: 99%
“…CDK1, a cell cycle regulator CDK family member, is the key molecule of the ATM-chk2-CDC25-CCNB1/CDK1 pathway that controls the cell cycle [24,25]. Xi et al showed that CDK1 expression is associated with ovarian cancer cell proliferation and can serve as an independent prognostic factor [26]. CCND1 stimulates G1 progression in responding to growth factor stimulation [27]; miR-211 down-regulation results in CCND1 and CDK6 overexpression, which increases the proliferative ability of EOC cells [28].SMARCD1, whose high expression predicts poorer prognosis in gastric cancer, functions as an oncogene by promoting gastric cancer cell proliferation, migration and invasion [29].…”
Section: Discussionmentioning
confidence: 99%
“…Smc1A (structural maintenance of chromosomes 1A) was associated with ubiquitin-mediated proteolysis [23]. CDK1 and CycB could mediate the cell division from G1 to S and G2 to M phases [24]. Rb1 (retinoblastoma-associated protein 1) and HDAC2 (histone deacetylase 2) were involved in apoptosis, S-phase, and DNA biosynthesis [25].…”
Section: Resultsmentioning
confidence: 99%
“…Goga et al [25] reported the inhibition of CDK1 gene resulting in downregulation of surviving expression and induction of MYC-dependent apoptosis. In addition, CDK1 gene silencing was shown to be a novel effective tool for treatment of epithelial ovarian cancer [26]. The expression of CDK2 is significantly correlated with the intrinsic breast cancer subtypes [27].…”
Section: Discussionmentioning
confidence: 99%